News
-
-
-
COMMUNIQUÉ DE PRESSE
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
TuHURA Biosciences, Inc. participated in the 2024 Maxim Healthcare Virtual Summit, sharing insights on overcoming resistance to cancer immunotherapy. The company is developing innovative technologies for immuno-oncology -
-
-
-
-
-
-